Assessing antihypertensive adherence with therapeutic drug monitoring Erika SW JONES, Maia LESOSKY, Marc BLOCKMAN, Sandra CASTEL, Eric H DECLOEDT,
|
|
- Bathsheba Chapman
- 5 years ago
- Views:
Transcription
1 Assessing antihypertensive adherence with therapeutic drug monitoring Erika SW JONES, Maia LESOSKY, Marc BLOCKMAN, Sandra CASTEL, Eric H DECLOEDT, Sylva LU SCHWAGER, Edward D STURROCK, Lubbe WIESNER, Brian L RAYNER
2 Time course of adherence/compliance parameters (execution, persistence) Vrijens, B. et al. BMJ 2008;336: Copyright 2008 BMJ Publishing Group Ltd.
3 1 year extra, but the good news it will seem like 15 years Doctor, if I take all these pills how long will I live?
4 Persistence, BP Control, and Events Data shows that people who drop out of treatment have: A 63% higher chance of death or first cardiovascular hospitalization A 74% increase in charges in annual medical care Patients who stop taking their medications end up with higher blood pressures and the attendant higher risk of cardiovascular events Elliott W. J Hypertens. 2000;18(suppl 4):S169.
5 Resistant hypertension? Assessment of adherence by toxicological urine analysis Jung, Oliver; Gechter, Janis L.; Wunder, Cora; Paulke, Alexander; Bartel, Christine; Geiger, Helmut; Toennes, Stefan W. Journal of Hypertension. 31(4): , April doi: /HJH.0b013e32835e2286 FIGURE 3. Percentage of prescribed drugs taken by nonadherent patients. Copyright 2014 Journal of Hypertension. Published by Lippincott Williams & Wilkins. 5
6
7 Renal Nerve Anatomy Allows a Catheter-Based Approach Spacing of e.g. 5 mm. Renal artery access via standard interventional technique 4-6 two-minute treatments per artery Proprietary RF generator Automated Low power Built-in safety algorithms 7
8 SBP at 6 mo Primary Efficacy Endpoint Office Systolic Blood Pressure at 6 Months, 5 mm Superiority Margin N = 353 N = 171 RDN Control P value Baseline SBP mo SBP Change P < P < (-6.89, 2.12), P = (Primary analysis with 5 mm Hg superiority margin) Did not meet primary efficacy endpoint
9 TOOLS OF ASSESSING/IMPROVING ADHERENCE Use of pillboxes Reminders/care givers Improved dosing schedule Single pill combinations Names of the medications, and dosage Self admitted non-adherence Medication possession ratios Electronic monitoring Therapeutic Drug Monitoring (TDM)
10 AIM To determine if TDM is valuable tool in the evaluation of patients referred for treatment of resistant hypertension
11 METHODS Patients attending a referral hypertension clinic for resistant hypertension that were prescribed enalapril and amlodipine (± other antihypertensives) were enrolled into the study After informed consent patients underwent BP monitoring, completed a questionnaire on adherence and blood samples were taken for amlodipine levels and ACE activity Patient demographics and medications were recorded Assessments were repeated at next follow up visit The study was approved by the University of Cape Town Human Research Ethics Committee.
12 METHODS 2 Amlodipine assay Plasma amlodipine concentrations were determined using a validated liquid chromatography-tandem mass spectrometry assay. A level of <2.5ng/ml for amlodipine was found to indicate nonadherence, ng/ml indeterminate and > 7ng/ml adherent ACE activity assay ACE activity was measured by the hydrolysis of two synthetic substrates [Z-Phe-His-Leu (ZFHL) and Hippuryl-His-Leu (HHL)] in a sensitive fluorimetric assay as described previously (Schwager et al. 2006). A Z-FHL/HHL ratio <1.75 was considered non-adherent
13 RESULTS Data were collected on 100 patients and follow up data for 65 patients 54% were female, 20% were Black African and 80% were Mixed Ancestry Mean age (±SD) was 50±12y Patients were taking 2-8 antihypertensives and 2-10 medications in total All patients were taking an ACE inhibitor and amlodipine 80% of patients were on 10mg amlodipine daily, and 88% were on 10mg enalapril twice a day Dose did not affect serum levels
14 Measures of adherence 90% issued their own medications 24% used pillboxes 90% of patients knew the dosing schedule 52% knew the names of the medications 40% knew the dose 33% admitted to forgetting their medication regularly Adherence measures showed no association with amlodipine concentrations or ACE activity.
15 BASELINE and FOLLOW UP Baseline Baseline Follow up P value* (n = 100) (n = 63) (n = 63) SBP (mmhg) 146 (127, 163) 147 (128, 161) 154 (130, 169) DBP (mmhg) 88 (74, 99) 88 (74, 100) 88.0 (77, 104) 0.55 Amlodipine level (ng/ml) 13.6 (5.1, 24.4) 16.1 (4.9, 25.3) 11.9 (3.1, 2.8) 0.34 Z-FHL/HHL ratio 2.61 (1.47, (1.9, 3.1) 2.2 (1.3, 2.8) 0.029
16 AMLODIPINE Adherent Non-adherent Indeterminate p-value* Visit 1 (n=100) 62 (62%) 20 (20%) 18 (18%) SBP 140 (122, 149) 166 (160, 187) 159 (138, 161) < DBP 84 (73, 91) 104 (96, 117) 93 (72, 106) < Visit 2 (n=65) 36 (55%) 14 (22%) 15 (23%) SBP 137 (126, 153) 169 (164, 179) 161 (137, 173) DBP 81 (74, 90) 106 (99, 115) 92 (90, 111) <
17 ACEi Adherent Non-adherent p-value* Visit 1 (n=97) 71 (73%) 26 (27%) SBP 142 (122, 156) 163 (143, 171) DBP 82 (72, 93) 102 (89, 114) < Visit 2 (n=58) 37 (64%) 21 (36%) SBP 149 (128, 164) 167 (158, 178) 0.01 DBP 86 (76, 93) 104 (92, 114) 0.004
18 2 patients with therapeutic amlodipine levels 6 patients with unsuppressed ACE BPs > 160/100 mmhg at the first visit
19 IMPLICATIONS Our findings suggest that TDM is an essential tool in evaluating patients with resistant hypertension It will identify patients with true resistance Reduce the need for expensive tests looking for a secondary cause, reduce pill burden and the costs of medications associated with polypharmacy Furthermore, TDM will focus attention on barriers to good adherence (for instance fixed drug combinations or side effects) An early diagnosis of lack of adherence could decrease pill burden and side effects associated with polypharmacy.
20 CONCLUSIONS TDM of antihypertensive medication identifies patients with poor adherence and poorly controlled BP This should become a routine part of the evaluation of resistant hypertension The pharmaco-ecomomic implications need to be established
21 Current Practice Amlodipine has become a routine part of clinic practice A simplified and cheaper methodology has been implemented with ranges < 0.5, , 2.5 7, and > 7 ng/ml A point of care assay is being considered
PRESCRIPTION PATTERN OF ANTI HYPERTENSIVE DRUGS IN SHRI SATHYA SAI MEDICAL COLLEGE & RESEARCH INSTITUTE
Original Article PRESCRIPTION PATTERN OF ANTI HYPERTENSIVE DRUGS IN SHRI SATHYA SAI MEDICAL COLLEGE & RESEARCH INSTITUTE Annamalai Maduram 1, Harikrishna 2 INTRODUCTION High blood pressure, termed "hypertension,"
More informationPBPK/PD Modeling and Simulations to Guide Dose Recommendation of Amlodipine with Viekirax or Viekira Pak
PBPK/PD Modeling and Simulations to Guide Dose Recommendation of Amlodipine with Viekirax or Viekira Pak Dwaipayan Mukherjee, Ph.D. Jiuhong Zha, Ph.D. Rajeev Menon, Ph.D. Mohamad Shebley, Ph.D. Clinical
More informationProceedings of the World Small Animal Veterinary Association Sydney, Australia 2007
Proceedings of the World Small Animal Veterinary Association Sydney, Australia 2007 Hosted by: Australian Small Animal Veterinary Association (ASAVA) Australian Small Animal Veterinary Association (ASAVA)
More informationSynopsis. Takeda Pharmaceutical Company Limited Name of the finished product UNISIA Combination Tablets LD, UNISIA Combination Tablets
Synopsis Name of the sponsor Takeda Pharmaceutical Company Limited Name of the finished product UNISIA Combination Tablets LD, UNISIA Combination Tablets Name of active ingredient Title of the study Study
More informationProceedings of the 36th World Small Animal Veterinary Congress WSAVA
www.ivis.org Proceedings of the 36th World Small Animal Veterinary Congress WSAVA Oct. 14-17, 2011 Jeju, Korea Next Congress: Reprinted in IVIS with the permission of WSAVA http://www.ivis.org 14(Fri)
More informationJMSCR Vol 05 Issue 03 Page March 2017
www.jmscr.igmpublication.org Impact Factor 5.84 Index Copernicus Value: 83.27 ISSN (e)-2347-176x ISSN (p) 2455-0450 DOI: https://dx.doi.org/10.18535/jmscr/v5i3.219 Comparative Study of Adverse Effect of
More informationStudy of the Side effects profile of different antihypertensive drugs among the Hypertensive patient
Study of the Side effects profile of different antihypertensive drugs among the Hypertensive patient Shrestha RK 1, Khan GM 1, Thapa P 1, Koju R 2 1 Department of Pharmacy, Kathmandu University 2 Department
More informationSAFETY PHARMACOLOGY: CARDIOVASCULAR TELEMETRY. Aileen Milne PhD, Manager, Safety Pharmacology
SAFETY PHARMACOLOGY: CARDIOVASCULAR TELEMETRY Aileen Milne PhD, Manager, Safety Pharmacology SAFETY PHARMACOLOGY SERVICES OVERVIEW Full Range of S7A and S7B studies herg assay Respiratory function plethysmography(rat/mouse)
More informationAMLODIPINE BESYLATE + OLMESARTAN MEDOXOMIL. Dihydropyridine Ca channel blocker [Dhp-CCB] + Angiotensin II receptor blockage [ARB]
AMLODIPINE BESYLATE + OLMESARTAN MEDOXOMIL Dihydropyridine Ca channel blocker [Dhp-CCB] + Angiotensin II receptor blockage [ARB] ESH/ESC HT MANAGEMENT GUIDELINE 2013 DIAGNOSIS TARGET BP TARGET BP CONTROL
More informationThe legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION. 23 January 2008
The legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION 23 January 2008 ZANIDIP 10mg, film-coated tablets B/28 (CIP: 347 638.7) B/30 (CIP: 372 259.6) B/90 (CIP: 372 260.4)
More informationOriginal Article. Introduction. Korean Circulation Journal
Original Article Print ISSN 1738-5520 On-line ISSN 1738-5555 Korean Circulation Journal Valsartan 160 mg/amlodipine 5 mg Combination Therapy versus Amlodipine 10 mg in Hypertensive Patients with Inadequate
More informationPublic Assessment Report Scientific discussion
Public Assessment Report Scientific discussion SE/H/1397/01-05/DC Ramipril/Amlodipine Sandoz (ramipril/amlodipine) Applicant: Sandoz A/S This module reflects the scientific discussion for the approval
More informationCats usually develop secondary hypertension with an
J Vet Intern Med 2015 Randomized Placebo-Controlled Clinical Trial of a Chewable Formulation of Amlodipine for the Treatment of Hypertension in Client-Owned Cats M. Huhtinen, G. Derre, H.J. Renoldi, M.
More informationAntihypertensive efficacy of amlodipine in children with chronic kidney diseases
(2001) 15, 387 391 2001 Nature Publishing Group All rights reserved 0950-9240/01 $15.00 www.nature.com/jhh ORIGINAL ARTICLE Antihypertensive efficacy of amlodipine in children with chronic kidney diseases
More informationSuitability of Antibiotic Treatment for CAP (CAPTIME) The duration of antibiotic treatment in community acquired pneumonia (CAP)
STUDY PROTOCOL Suitability of Antibiotic Treatment for CAP (CAPTIME) Purpose The duration of antibiotic treatment in community acquired pneumonia (CAP) lasts about 9 10 days, and is determined empirically.
More informationObjectives 4/26/2017. Co-Investigators Sadie Giuliani, PharmD, BCPS Claude Tonnerre, MD Jayme Hartzell, PharmD, MS, BCPS
IMPLEMENTATION AND ASSESSMENT OF A GUIDELINE-BASED TREATMENT ALGORITHM FOR COMMUNITY-ACQUIRED PNEUMONIA (CAP) Lucas Schonsberg, PharmD PGY-1 Pharmacy Practice Resident Providence St. Patrick Hospital Missoula,
More informationCopyright is owned by the Author of the thesis. Permission is given for a copy to be downloaded by an individual for the purpose of research and
Copyright is owned by the Author of the thesis. Permission is given for a copy to be downloaded by an individual for the purpose of research and private study only. The thesis may not be reproduced elsewhere
More informationIMPLEMENTATION AND ASSESSMENT OF A GUIDELINE-BASED TREATMENT ALGORITHM FOR COMMUNITY-ACQUIRED PNEUMONIA (CAP)
IMPLEMENTATION AND ASSESSMENT OF A GUIDELINE-BASED TREATMENT ALGORITHM FOR COMMUNITY-ACQUIRED PNEUMONIA (CAP) Lucas Schonsberg, PharmD PGY-1 Pharmacy Practice Resident Providence St. Patrick Hospital Missoula,
More informationTolerance and safety of enalapril
Br. J. clin. Pharmac. (1984), 18, 249S-253S Tolerance and safety of enalapril W. McFATE SMITH, R. 0. DAVIES, M. A. GABRIEL, D. M. KRAMSCH, F. MONCLOA, JANET E. RUSH & J. F. WALKER Merck Sharp & Dohme Research
More informationM5 MEQs 2016 Session 3: SOB 18/11/16
M5 MEQs 2016 Session 3: SOB 18/11/16 http://tinyurl.com/hn7qzt3 Question 1 Ms Tan is a 52 year old female with no past medical history. She comes to the emergency department presenting with a fever for
More informationPromoting rational antibiotic prophylaxis in clean surgeries in China
ESSENTIAL MEDICINES MONITOR 5 Promoting rational antibiotic prophylaxis in clean surgeries in China = Yingdong Zheng, Jing Sun, Ying Zhou, Ning Chen, Liang Zhou, Qing Yan Background World Health Assembly
More informationThe 4 th Generation calcium channel blocker C I L N I D I P I N E
T The 4 th Generation calcium channel blocker C I L N I D I P I N E = TOp DUal Action New Ca 2+ Channel Blocker Cilnidipine (IHS) - C 27 H 28 N 2 O 7 INDICATION Essential Hypertension DOSAGE & PACKAGE
More informationPneumonia Antibiotic Guidance for Adults PAGL Inclusion Approved at January 2017 PGC
Pneumonia Antibiotic Guidance for Adults PAGL Inclusion Approved at January 2017 PGC APPROVED BY: Policy and Guidelines Committee TRUST REFERENCE: B9/2009 AWP Ref: AWP61 Date (approved): July 2008 REVIEW
More informationCOST VARIATION ANALYSIS OF ANTIHYPERTENSIVE DRUGS AVAILABLE IN INDIAN MARKET: AN ECONOMIC PERSPECTIVE
IJPSR (2016), Vol. 7, Issue 5 (Research Article) Received on 03 December, 2015; received in revised form, 14 January, 2016; accepted, 07 February, 2016; published 01 May, 2016 COST VARIATION ANALYSIS OF
More informationAmerican Association of Feline Practitioners American Animal Hospital Association
American Association of Feline Practitioners American Animal Hospital Association Basic Guidelines of Judicious Therapeutic Use of Antimicrobials August 1, 2006 Introduction The Basic Guidelines to Judicious
More informationPOPULATION PHARMACOKINETICS AND PHARMACODYNAMICS OF OFLOXACIN IN SOUTH AFRICAN PATIENTS WITH DRUG- RESISTANT TUBERCULOSIS
POPULATION PHARMACOKINETICS AND PHARMACODYNAMICS OF OFLOXACIN IN SOUTH AFRICAN PATIENTS WITH DRUG- RESISTANT TUBERCULOSIS Emmanuel Chigutsa 1, Sandra Meredith 1, Lubbe Wiesner 1, Nesri Padayatchi 2, Joe
More informationCLINICAL PROTOCOL FOR COMMUNITY ACQUIRED PNEUMONIA. SCOPE: Western Australia. CORB score equal or above 1. All criteria must be met:
CLINICAL PROTOCOL F COMMUNITY ACQUIRED PNEUMONIA SCOPE: Western Australia All criteria must be met: Inclusion Criteria Exclusion Criteria CB score equal or above 1. Mild/moderate pneumonia confirmed by
More informationWelcome! 10/26/2015 1
Welcome! Audio for this event is available via ReadyTalk Internet Streaming. No telephone line is required. Computer speakers or headphones are necessary to listen to streaming audio. Limited dial-in lines
More informationHost, Syndrome, Bug, Drug: Introducing 2 Frameworks to Approach Infectious Diseases Cases with an Antimicrobial Stewardship Focus
Host, Syndrome, Bug, Drug: Introducing 2 Frameworks to Approach Infectious Diseases Cases with an Antimicrobial Stewardship Focus Montana ACP Meeting 2018 September 8, 2018 Staci Lee, MD, MEHP Billings
More informationOxygenation in Medetomidine-Sedated Dogs with and without 100% Oxygen Insufflation
J. C. H. Ko, A. B. Weil, T. Kitao, M. E. Payton, and T. Inoue Oxygenation in Medetomidine-Sedated Dogs with and without 100% Oxygen Insufflation Jeff C. H. Ko, DVM, MS, DACVA a Ann B. Weil, DVM, MS, DACVA
More informationC o n v e r s i b e n a z e p r. l i s i n o p r
C o n v e r s i b e n a z e p r t o l i s i n o p r Ace-inhibitor conversions. Common Medication Conversions (Equivalents) Ace Inhibitors : Drug Comparisons - Home Page. Hydrochlorothiazide; lisinopril
More informationPublic Assessment Report Scientific discussion. Perindopril tert-butylamine/amlodipine Stada (perindopril and amlodipine) SE/H/1500/01-04/DC
Public Assessment Report Scientific discussion Perindopril tert-butylamine/amlodipine Stada (perindopril and amlodipine) SE/H/1500/01-04/DC This module reflects the scientific discussion for the approval
More informationAntimicrobial Stewardship In Residential Aged Care Facilities
Poster Session HRT11420 Innovation Awards November 2014 Melbourne Antimicrobial Stewardship In Residential Aged Care Facilities Elizabeth Orr: Monash Health: Elevator Pitch- A pilot project was conducted
More informationCommonwealth of Kentucky Antibiotic Stewardship Practice Assessment For Long-Term Care Facilities
Commonwealth of Kentucky Antibiotic Stewardship Practice Assessment For Long-Term Care Facilities Introduction As the problem of antibiotic resistance continues to worsen in all healthcare setting, we
More informationThese recommendations were approved for use by the Pharmaceutical and Therapeutics Committee, RCWMCH on 1 February 2017.
Antibiotic regimens for suspected hospital-acquired infection (HAI) outside the Paediatric Intensive Care Unit at Red Cross War Memorial Children s Hospital (RCWMCH) Lead author: Brian Eley Contributing
More informationEffects of Moxifloxacin PK-PD and drug interactions on its use in the Treatment of Tuberculosis(TB)
Effects of Moxifloxacin PK-PD and drug interactions on its use in the Treatment of Tuberculosis(TB) Session: Fanning the Flames of HIV and TB Cointeraction SA AIDS Conference-Durban ICC 13-15 June 2017
More informationScholars Research Library. Investigation of antibiotic usage pattern: A prospective drug utilization review
Available online at www.scholarsresearchlibrary.com Scholars Research Library Der Pharmacia Lettre, 2011: 3 (5) 301-306 (http://scholarsresearchlibrary.com/archive.html) ISSN 0974-248X USA CODEN: DPLEB4
More informationIJBCP International Journal of Basic & Clinical Pharmacology. Adverse drug effects monitoring of amlodipine in a tertiary care hospital
Print ISSN: 2319-2003 Online ISSN: 2279-0780 IJBCP International Journal of Basic & Clinical Pharmacology DOI: http://dx.doi.org/10.18203/2319-2003.ijbcp20182069 Original Research Article Adverse drug
More informationUniversity of Cape Town
l1li.. I I l1li III I The copyright of this thesis vests in the author. No quotation from it or information derived from it is to be published without full acknowledgement of the source. The thesis is
More informationGang LING, Ai-jun LIU, Fu-ming SHEN, Guo-jun CAI, Jian-guo LIU, Ding-feng SU 2
Acta Pharmacol Sin 2007 Nov; 28 (11): 1755 1760 Full-length article Effects of combination therapy with atenolol and amlodipine on blood pressure control and stroke prevention in stroke-prone spontaneously
More informationGovernment Initiatives to Combat Antimicrobial Resistance (AMR)
Government Initiatives to Combat Antimicrobial Resistance (AMR) in the Philippines Ma. Virginia G. Ala, MD, MPH, CESO III Director IV and Program Manager National Center for Pharmaceutical Access and Management,
More informationObjective 1/20/2016. Expanding Antimicrobial Stewardship into the Outpatient Setting. Disclosure Statement of Financial Interest
Expanding Antimicrobial Stewardship into the Outpatient Setting Michael E. Klepser, Pharm.D., FCCP Professor Pharmacy Practice Ferris State University College of Pharmacy Disclosure Statement of Financial
More informationNUOVE IPOTESI e MODELLI di STEWARDSHIP
Esperienze di successo di antimicrobial stewardship Bologna, 18 novembre 2014 NUOVE IPOTESI e MODELLI di STEWARDSHIP Pierluigi Viale Clinica di Malattie Infettive Policlinico S. Orsola Malpighi Interventions
More informationStewardship tools. Dilip Nathwani Ninewells Hospital and Medical School Dundee, UK
Stewardship tools Dilip Nathwani Ninewells Hospital and Medical School Dundee, UK What is Antimicrobial Stewardship (AMS)? Antimicrobial stewardship has been defined as the optimal selection, dosage, and
More informationResearch & Reviews: Journal of Hospital and Clinical Pharmacy
Research & Reviews: Journal of Hospital and Clinical Pharmacy Empiric Antibiotic Prescribing For Community Acquired Pneumonia and Patient Characteristics Associated with Broad Spectrum Antibiotic Use Mirza
More informationNursing intervention for amlodipine
Nursing intervention for amlodipine Amlodipine is a calcium channel blocking agent that selectively blocks calcium ion reflux across cell membranes of cardiac and vascular smooth muscle without. PHYSICAL
More informationng h/ml, C max values were 54Æ8 ±29Æ5 and 57Æ2 ±29Æ0ng/mL, T max values were 4Æ6 ±1Æ6 h and 4Æ3 ±1Æ45 h, and t 1/2 ranged between 1Æ1 to
Journal of Clinical Pharmacy and Therapeutics (2005) 30, 319 328 ORIGINAL ARTICLE Pharmacokinetics and pharmacodynamics profiles of enalapril maleate in healthy volunteers following determination of enalapril
More informationCurricular Components for Infectious Diseases EPA
Curricular Components for Infectious Diseases EPA 1. EPA Title Promoting antimicrobial stewardship based on microbiological principles 2. Description of the A key role for subspecialists is to utilize
More informationANTIMICROBIAL STEWARDSHIP IN PRIMARY HEALTH CARE WESTERN CAPE GOVERNMENT: HEALTH METRO DISTRICT FINDINGS 6 MONTHS AFTER INITIATION
ANTIMICROBIAL STEWARDSHIP IN PRIMARY HEALTH CARE WESTERN CAPE GOVERNMENT: HEALTH METRO DISTRICT FINDINGS 6 MONTHS AFTER INITIATION 2018 IHI Africa Forum for Quality and Safety in Healthcare Bart Willems,
More informationClinical Study Synopsis
Clinical Study Synopsis This Clinical Study Synopsis is provided for patients and healthcare professionals to increase the transparency of Bayer's clinical research. This document is not intended to replace
More informationExecutive Summary: A Point Prevalence Survey of Antimicrobial Use: Benchmarking and Patterns of Use to Support Antimicrobial Stewardship Efforts
Executive Summary: A Point Prevalence Survey of Antimicrobial Use: Benchmarking and Patterns of Use to Support Antimicrobial Stewardship Efforts Investigational Team: Diane Brideau-Laughlin BSc(Pharm),
More informationSUMMARY OF PRODUCT CHARACTERISTICS
SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Amodip 1.25 mg chewable tablets for cats 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains Active substance:
More informationRENT THERAPEUTIC RESEARC~ VOLUME 66, NUMBER 2, MARcH/APRIL 2005
RENT THERAPEUTIC RESEARC~ VOLUME 66, NUMBER 2, MARcH/APRIL 2005 Bioavailability Study of Fixed-Dose Tablet Versus Capsule Formulation of Amlodipine Plus Benazepril: A Randomized, Single-Dose, Two-Sequence,
More informationCOMMITTEE FOR MEDICINAL PRODUCTS FOR VETERINARY USE
European Medicines Agency Veterinary Medicines and Inspections EMEA/CVMP/211249/2005-FINAL July 2005 COMMITTEE FOR MEDICINAL PRODUCTS FOR VETERINARY USE DIHYDROSTREPTOMYCIN (Extrapolation to all ruminants)
More informationSAMPLE. Certificate in Understanding the Safe Handling of Medication in Health and Social Care PRESCRIPTION. Workbook 1 LEGISLATION.
NCFE Level 2 Certificate in Understanding the Safe Handling of Medication in Health and Social Care ACCOUNTABILITY PRESCRIPTION ADMINISTRATION STORAGE SUPPLY LEGISLATION 1 LCG 2015 This section will introduce
More informationSurvival after diagnosis of hypertension in cats attending primary care practice in the United Kingdom
Received: 19 March 2017 Revised: 28 April 2018 Accepted: 24 July 2018 DOI: 10.1111/jvim.15307 STANDARD ARTICLE Survival after diagnosis of hypertension in cats attending primary care practice in the United
More informationOptimizing Antimicrobial Stewardship Activities Based on Institutional Resources
Optimizing Antimicrobial Stewardship Activities Based on Institutional Resources Andrew Hunter, PharmD, BCPS Infectious Diseases Clinical Pharmacy Specialist Michael E. DeBakey VA Medical Center Andrew.hunter@va.gov
More informationPDF of Trial CTRI Website URL -
Clinical Trial Details (PDF Generation Date :- Sun, 10 Mar 2019 06:52:14 GMT) CTRI Number Last Modified On 29/07/2016 Post Graduate Thesis Type of Trial Type of Study Study Design Public Title of Study
More informationAustralian and New Zealand College of Veterinary Scientists. Membership Examination. Small Animal Medicine Paper 1
Australian and New Zealand College of Veterinary Scientists Membership Examination June 2015 Small Animal Medicine Paper 1 Perusal time: Fifteen (15) minutes Time allowed: Two (2) hours after perusal Answer
More informationDosage equivalent lisinopril amlodipine
Dosage equivalent 09/22/2017 Sons massage goes to far vol 2 09/23/2017 Integer game printable 09/25/2017 -Senior night invitation for parents -Games for anger management teenagers 09/26/2017 Minecraft
More informationAcute Pyelonephritis POAC Guideline
Acute Pyelonephritis POAC Guideline Refer full regional pathway http://aucklandregion.healthpathways.org.nz/33444 EXCLUSION CRITERIA: COMPLICATED PYELONEPHRITIS Discuss with relevant specialist for advice
More informationManaging winter illnesses without antibiotics
CLINICAL AUDIT Managing winter illnesses without antibiotics Valid to June 2023 bpac nz better medicin e Background Over the winter months, thousands of people across New Zealand will present to primary
More informationFACTORS AFFECTING THE POST-DIALYSIS LEVELS OF VANCOMYCIN AND GENTAMICIN IN HAEMODIALYSIS PATIENTS. Acute-Haemodialysis Team St.
FACTORS AFFECTING THE POST-DIALYSIS LEVELS OF VANCOMYCIN AND GENTAMICIN IN HAEMODIALYSIS PATIENTS. Acute-Haemodialysis Team St. Helier s Hospital Vancomycin and Gentamicin Audit Renal Unit St Helier Hospital
More informationMINISTRY OF HEALTH, MALAYSIA
LAMPIRAN C Ref. No : Photo 4 x 6 ( Part I : Personal information ) 1. FULL NAME ( FIRST NAME) : ( FATHER'S NAME) : 2. MALE/FEMALE : 3. AGE : 7. NAME OF EMPLOYER / RECRUITING AGENCY : 8. ADDRESS OF EMPLOYER
More informationGARP ACTIVITIES IN KENYA. Sam Kariuki and Cara Winters
GARP ACTIVITIES IN KENYA Sam Kariuki and Cara Winters GARP-Kenya Situation Analysis Status of Conditions Related to Antibiotic Resistance 2010 Report Organization I. Health System Overview and Disease
More informationUnited Kingdom Veterinary Medicines Directorate Woodham Lane New Haw Addlestone Surrey KT15 3LS DECENTRALISED PROCEDURE
United Kingdom Veterinary Medicines Directorate Woodham Lane New Haw Addlestone Surrey KT15 3LS DECENTRALISED PROCEDURE PUBLICLY AVAILABLE ASSESSMENT REPORT FOR A VETERINARY MEDICINAL PRODUCT Amodip 1.25
More informationAmlodipine 5 Mg Tab Cam
Amlodipine 5 Mg Tab Cam what is amlodipine 10 mg used for thuoc amlodipine besylate tablets 5 mg amlodipine 5 mg plus atenolol 50 mg amlodipine 5 mg cost amlodipine besylate 10 mg per tablet amlodipine
More informationPatients. Excludes paediatrics, neonates.
Full title of guideline Author Division & Speciality Scope Gentamicin Prescribing Guideline For Adult Patients Annette Clarkson, Specialist Clinical Pharmacist Antimicrobials and Infection Control All
More informationAustralian and New Zealand College of Veterinary Scientists. Membership Examination. Medicine of Cats Paper 1
Australian and New Zealand College of Veterinary Scientists Membership Examination June 2016 Medicine of Cats Paper 1 Perusal time: Fifteen (15) minutes Time allowed: Two (2) hours after perusal Answer
More informationPharma Research Library. 2013, Vol. 1(1):19-29
Available online at www.pharmaresearchlibrary.com Pharma Research Library International Journal of Current Trends in Pharmaceutical Research 2013, Vol. 1(1):19-29 Pharma Research Library Method development
More informationLUPIN LIMITED SAFETY DATA SHEET. Section 1: Identification MADE IN INDIA
LUPIN LIMITED SAFETY DATA SHEET Section 1: Identification Section 1, Identification Material Manufacturer Distributor Amlodipine Besylate Tablets USP 2.5 mg, 5 mg and 10 mg Lupin Limited MADE IN INDIA
More informationمادة االدوية المرحلة الثالثة م. غدير حاتم محمد
م. مادة االدوية المرحلة الثالثة م. غدير حاتم محمد 2017-2016 ANTIMICROBIAL DRUGS Antimicrobial drugs Lecture 1 Antimicrobial Drugs Chemotherapy: The use of drugs to treat a disease. Antimicrobial drugs:
More informationLUPIN LIMITED SAFETY DATA SHEET. Section 1: Identification. Amlodipine and Valsartan Tablets 5/160 mg, 10/160 mg, 5/320 mg and 10/320 mg
LUPIN LIMITED SAFETY DATA SHEET Section 1: Identification Section 1, Identification Material Manufacturer Distributor Amlodipine and Valsartan Tablets 5/160 mg, 10/160 mg, 5/320 mg and 10/320 mg Lupin
More informationNew Antibiotics for MRSA
New Antibiotics for MRSA Faculty Warren S. Joseph, DPM, FIDSA Consultant, Lower Extremity Infectious Diseases Roxborough Memorial Hospital Philadelphia, Pennsylvania Faculty Disclosure Dr. Joseph: Speaker
More informationDelegating to Auxiliaries in Food Animal & Equine Practice
Delegating to Auxiliaries in Food Animal & Equine Practice Approved by Council: June 2004; September 2006; June 2011 Indirect definition modified June 9, 2010 Publication Date: Update September 2004, Website
More informationStewardship: Challenges & Opportunities in the Gulf Region
Stewardship: Challenges & Opportunities in the Gulf Region Mushira Enani, MBBS, FRCPE, FACP,CIC Head- Infectious Disease Section King Fahad Medical City Outline Background of Healthcare system in GCC GCC
More information4. The use of antibiotics without a prescription in seven EU Member States
4. The use of antibiotics without a prescription in seven EU Member States Main findings The results are based upon telephone interviews in seven Member States (Cyprus, Estonia, Greece, Hungary, Italy,
More informationBackground and Plan of Analysis
ENTEROCOCCI Background and Plan of Analysis UR-11 (2017) was sent to API participants as a simulated urine culture for recognition of a significant pathogen colony count, to perform the identification
More informationPharmacokinetic & Pharmadynamic of Once Daily Aminoglycosides (ODA) and their Monitoring. Janis Chan Pharmacist, UCH 2008
Pharmacokinetic & Pharmadynamic of Once Daily Aminoglycosides (ODA) and their Monitoring Janis Chan Pharmacist, UCH 25-4-2008 2008 Aminoglycosides (AG) 1. Gentamicin 2. Amikacin 3. Streptomycin 4. Neomycin
More informationsingle intravenous and oral doses and after 14 repeated oral
Br. J. clin. Pharmac. (1986), 22, 21-25 The pharmacokinetics of amlodipine in healthy volunteers after single intravenous and oral doses and after 14 repeated oral doses given once daily J. K. FAULKNER
More informationLefamulin Evaluation Against Pneumonia (LEAP 1) Phase 3 Topline Results. September 18, 2017
Lefamulin Evaluation Against Pneumonia (LEAP 1) Phase 3 Topline Results September 18, 2017 Safe Harbor and Disclaimer Any statements in this presentation about future expectations, plans and prospects
More informationPATIENT INFORMATION LEAFLET ACCEL-AMLODIPINE. Amlodipine Tablets 5 mg and 10 mg amlodipine (as amlodipine besylate) Antihypertensive-Antianginal Agent
PATIENT INFORMATION LEAFLET Pr ACCEL-AMLODIPINE Amlodipine Tablets 5 mg and 10 mg amlodipine (as amlodipine besylate) Antihypertensive-Antianginal Agent ACTION AND CLINICAL PHARMACOLOGY ACCEL-AMLODIPINE
More informationHealthcare Facilities and Healthcare Professionals. Public
Document Title: DOH Guidelines for Antimicrobial Stewardship Programs Document Ref. Number: DOH/ASP/GL/1.0 Version: 1.0 Approval Date: 13/12/2017 Effective Date: 14/12/2017 Document Owner: Applies to:
More information1 INDICATIONS AND USAGE. 1.1 Hypertension FULL PRESCRIBING INFORMATION
HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use AMLODIPINE besylate tablets USP safely and effectively. See full prescribing information for AMLODIPINE
More informationAMLODIPINE BESILATE / ATORVASTATIN CALCIUM
1. THERAPEUTIC CATEGORY Calcium Channel Blocker Lipid Regulating Agent AMLODIPINE BESILATE / ATORVASTATIN CALCIUM NORVASC PROTECT 2. FORMULATION Amlodipine besilate/atorvastatin calcium (Norvasc Protect)
More informationCommunity-acquired pneumonia: Time to place a CAP on length of treatment?
LOGIN TO LEARN: An Engaging and Interactive Journal Club for Pharmacists and Students Community-acquired pneumonia: Time to place a CAP on length of treatment? Jennifer Ball, PharmD Learning Objectives
More informationControl and monitoring of the use of antibiotics as a strategy against antimicrobials resistance
Control and monitoring of the use of antibiotics as a strategy against antimicrobials resistance Christiane Santiago Maia ANVISA - Brazilian Health Regulatory Agency s Context The burden of deaths from
More informationIrish Greyhound Board. Scientific Advisory Committee on Doping and Medication Control. Opinion on Carprofen
Irish Greyhound Board Scientific Advisory Committee on Doping and Medication Control Opinion on Carprofen The Committee has been examining the advice it would give the Board on the threshold for carprofen
More informationAntibiotics utilization ratio in a Neonatal Intensive Care Unit
Antibiotics utilization ratio in a Neonatal Intensive Care Unit Vera Rodrigues, Sandra Santos, Raquel Maia, Maria Teresa Neto, Micaela Serelha Neonatal Intensive Care Unit Hospital de Dona Estefânia, Centro
More informationAmlodipine Passage into Breast Milk in Lactating Women with Pregnancy-Induced Hypertension and Its Estimation of Infant Risk for Breastfeeding
56195JHLXXX1.1177/8933441456195Journal of Human LactationNaito et al research-article214 Original Research Amlodipine Passage into Breast Milk in Lactating Women with Pregnancy-Induced Hypertension and
More informationLUPIN LIMITED SAFETY DATA SHEET. Section 1: Identification. Telmisartan and Amlodipine Tablets 40 mg/5 mg; 40 mg/10 mg; 80 mg/5 mg and 80 mg/10 mg
LUPIN LIMITED SAFETY DATA SHEET Section 1: Identification Section 1, Identification Material Manufacturer Distributor Telmisartan and Amlodipine Tablets 40 mg/5 mg; 40 mg/10 mg; 80 mg/5 mg and 80 mg/10
More informationStudy population The target population for the model were hospitalised patients with cellulitis.
Comparison of linezolid with oxacillin or vancomycin in the empiric treatment of cellulitis in US hospitals Vinken A G, Li J Z, Balan D A, Rittenhouse B E, Willke R J, Goodman C Record Status This is a
More informationCore Elements of Antibiotic Stewardship for Nursing Homes
Core Elements of Antibiotic Stewardship for Nursing Homes Nimalie D. Stone, MD, MS Medical Epidemiologist for LTC Division of Healthcare Quality Promotion Centers for Disease Control and Prevention Antimicrobial
More informationGUIDE TO THE PROFESSIONAL PRACTICE STANDARD
GUIDE TO THE PROFESSIONAL PRACTICE STANDARD Use of Compounded Products in Veterinary Practice Published: December 2014 Introduction The College s Professional Practice Standard: Use of Compounded Products
More informationHEADWAY 2.0% TOPICAL SOLUTION
HEADWAY 2.0% TOPICAL SOLUTION Minoxidil 2.0% Topical Solution Submission for Reclassification October 2001 MINOXIDIL 2.0% TOPICAL SOLUTION Submission for Reclassification Page 2 BACKGROUND TO THE SUBMISSION...
More informationPage 1 of 21. Tablets: 2.5 mg, 5 mg, and 10 mg (3)
HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use AMLODIPINE BESYLATE TABLETS safely and effectively. See full prescribing information for AMLODIPINE
More informationDevelopment and validation of a HPLC analytical assay method for amlodipine besylate tablets: A Potent Ca +2 channel blocker
Development and validation of a HPLC analytical assay method for amlodipine besylate tablets: A Potent Ca +2 channel blocker Richa Sah* and Saahil Arora 1. ISF College of Pharmacy, Moga, Punjab, India
More informationCephalosporins, Quinolones and Co-amoxiclav Prescribing Audit
Cephalosporins, Quinolones and Co-amoxiclav Prescribing Audit Executive Summary Background Antibiotic resistance poses a significant threat to public health, as antibiotics underpin routine medical practice.
More informationClinical trials conducted in subjects with naturally
Review J Vet Intern Med 2013 Evidence-Based Medicine: The Design and Interpretation of Noninferiority Clinical Trials in Veterinary Medicine K.J. Freise, T.-L. Lin, T.M. Fan, V. Recta, and T.P. Clark Noninferiority
More informationcongestive heart failure
Br. J. clin. Pharmac. (1987), 23, 43-41 The pharmacokinetics of enalapril in hospitalized patients with congestive heart failure K. DICKSTEIN, A. E. TILL, T. AARSLAND, K. TJELTA, A. M. ABRAHAMSEN, K. KRISTIANSON,
More information